FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498397012 Tablet en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet Is a Unit of presentation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely nicotinic acid 500 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely albendazole 200 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely aspirin 385 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 385 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 385 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely aspirin 428 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 428 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 428 milligram and caffeine 30 milligram and orphenadrine citrate 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely aspirin 856 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 856 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 856 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 500 milligram and hydrocodone bitartrate 5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 500 milligram and hydrocodone bitartrate 5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 325 milligram and meprobamate 200 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 325 milligram and meprobamate 200 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 325 milligram and methocarbamol 400 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 325 milligram and methocarbamol 400 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 4.5 milligram and oxycodone terephthalate 380 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 4.5 milligram and oxycodone terephthalate 380 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 4.5 milligram and oxycodone terephthalate 380 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely atenolol 100 milligram and chlortalidone 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely atenolol 100 milligram and chlortalidone 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely atenolol 50 milligram and chlortalidone 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely atenolol 50 milligram and chlortalidone 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely azatadine maleate 1 milligram and pseudoephedrine sulfate 120 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely azatadine maleate 1 milligram and pseudoephedrine sulfate 120 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely benazepril hydrochloride 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely benazepril hydrochloride 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely captopril 25 milligram and hydrochlorothiazide 15 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely captopril 25 milligram and hydrochlorothiazide 15 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely captopril 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely captopril 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely captopril 50 milligram and hydrochlorothiazide 15 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely captopril 50 milligram and hydrochlorothiazide 15 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely homatropine methylbromide 1.5 milligram and hydrocodone bitartrate 5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely homatropine methylbromide 1.5 milligram and hydrocodone bitartrate 5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 3
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely methscopolamine 2.5 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely methscopolamine 2.5 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely methyclothiazide 2.5 milligram and reserpine 100 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely methyclothiazide 2.5 milligram and reserpine 100 microgram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amiloride hydrochloride 5 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amiloride hydrochloride 5 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amitriptyline 10 milligram and perphenazine 4 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amitriptyline 10 milligram and perphenazine 4 milligram/1 each conventional release oral tablet Has presentation strength denominator unit False Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely olmesartan medoxomil 5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely olmesartan medoxomil 20 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1

Start Previous Page 6 of 153 Next End

This concept is not in any reference sets

Back to Start